Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-030180
Filing Date
2024-12-26
Accepted
2024-12-26 20:05:18
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 form4-12272024_011215.html 4  
1 form4-12272024_011215.xml 4 3817
  Complete submission text file 0001415889-24-030180.txt   5242
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Gujrathi Sheila (Reporting) CIK: 0001575202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 241582038

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)